Acrivon Therapeutics, Inc. · NASDAQ:ACRV

RA Capital Nexus Fund II, L.P. received 3,888,888 Acrivon Therapeutics, Inc. shares as an award (Form 4)

Traded Apr 22, 2026 · Filed Apr 23, 2026

On Apr 22, 2026, RA Capital Nexus Fund II, L.P. (Director) received 3,888,888 Acrivon Therapeutics, Inc. shares as an award at US$1.80 for US$7M, leaving 11,803,094 shares. Filed Apr 23, 2026 (Form 4).

Awarded
3,888,888 shares
Price
US$1.80
Value
US$7M
Holding after
11,803,094 shares (held indirectly)
Trading plan
No
Role
Director

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Apr 22, 2026Common StockAward3,888,888US$1.8011,803,094Indirect

Source

View original at SEC

Related